Enhanced Low-Neutron-Flux Sensitivity Effect in Boron-Doped Silicon by Guixia Yang, Kunlin Wu, Jianyong Liu, Dehui Zou, Junjie Li, Yi Lu, Xueyang Lv, Jiayun Xu, Liang Qiao, Xuqiang Liu

Get full text

Mechanochemical coupling of MGF mediates periodontal regeneration by Ying Zhao, Songbai Zhang, Bo Cheng, Fan Feng, Yue Zhu, Yanli Liu, Junjun Wang, Dehui Zou, Heng Ma, Feng Xu, Min Zhang

Get full text

The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma by Huihsou Fan, Wenqiang Yan, Lingna Li, Jingyu Xu, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chenxing Du, Shuhua Yi, Dehui Zou, Lugui Qiu, Gang An

Get full text

Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China by Yuting Yan, Yuting Yan, Rui Lv, Rui Lv, Tingyu Wang, Tingyu Wang, Ying Yu, Ying Yu, Yanshan Huang, Yanshan Huang, Wenjie Xiong, Wenjie Xiong, Yuxi Li, Yuxi Li, Weiwei Sui, Weiwei Sui, Qi Wang, Qi Wang, Wenyang Huang, Wenyang Huang, Gang An, Gang An, Dehui Zou, Dehui Zou, Jianxiang Wang, Jianxiang Wang, Lugui Qiu, Lugui Qiu, Shuhua Yi, Shuhua Yi

Get full text

P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA by Hesong Zou, Wei Liu, Dandan Shan, Huimin Liu, Ting Xie, Wenyang Huang, Yi Wang, Shuhua Yi, Yan Xu, Gang An, Weiwei Sui, Tingyu Wang, Lugui Qiu, Dehui Zou

Get full text

Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma by Wenqiang Yan, Huishou Fan, Jingyu Xu, Jiahui Liu, Lingna Li, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Dehui Zou, Lugui Qiu, Gang An, Rongman Jia, Xiuyuan Hao

Get full text

Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia by Ying Yu, Wenjie Xiong, Tingyu Wang, Yuting Yan, Rui Lyu, Qi Wang, Wei Liu, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Jianxiang Wang, Lugui Qiu, Shuhua Yi

Get full text

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma by Chenxing Du, Lingna Li, Huishou Fan, Xuehan Mao, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chengwen Li, Jiawei Zhao, Shuhua Yi, Mu Hao, Dehui Zou, Yaozhong Zhao, Lugui Qiu, Gang An

Get full text

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China by Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Daobin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, Yuqin Song, Jun Zhu

Get full text

Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients by Wenjie Xiong, Tingyu Wang, Ying Yu, Yang Jiao, Jiawen Chen, Yi Wang, Chengwen Li, Rui Lyu, Qi Wang, Wei Liu, Weiwei Sui, Gang An, Dehui Zou, Lugui Qiu, Shuhua Yi, Rongman Jia, Xiuyuan Hao

Get full text

Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia by Wenjie Xiong, Wenjie Xiong, Wenjie Xiong, Zanzan Wang, Tingyu Wang, Tingyu Wang, Tingyu Wang, Ying Yu, Ying Yu, Ying Yu, Yanshan Huang, Yanshan Huang, Yanshan Huang, Hao Sun, Hao Sun, Hao Sun, Jiawen Chen, Jiawen Chen, Jiawen Chen, Rui Lyu, Rui Lyu, Rui Lyu, Huijun Wang, Huijun Wang, Huijun Wang, Yuting Yan, Yuting Yan, Yuting Yan, Qi Wang, Qi Wang, Qi Wang, Wei Liu, Wei Liu, Wei Liu, Gang An, Gang An, Gang An, Weiwei Sui, Weiwei Sui, Weiwei Sui, Wenyang Huang, Wenyang Huang, Wenyang Huang, Dehui Zou, Dehui Zou, Dehui Zou, Zhijian Xiao, Zhijian Xiao, Zhijian Xiao, Jianxiang Wang, Jianxiang Wang, Jianxiang Wang, Guifang Ouyang, Lugui Qiu, Lugui Qiu, Lugui Qiu, Shuhua Yi, Shuhua Yi, Shuhua Yi

Get full text

Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy by Wei Liu, Yan Xu, Yi Wang, Lugui Qiu, Ting Xie, Xiaojuan Wang, Huimin Liu, Tonghui Ma, Jianxiang Wang, Gang An, Weiwei Sui, Hesong Zou, Chunyang Wang, Chen Qiu, Dandan Shan, Wenyang Huang, Shuhua Yi, Dehui Zou

Get full text

P1203: EFFICACY AND SAFETY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSE/REFRACTORY NON-HODGKIN LYMPHOMA: FIRST REAL-WORLD DATA IN CHINESE POPULATION by LI Wang, Yuhua LI, Dehui Zou, Xiaojian Zhu, Dongmei Ji, Wenbin Qian, Ying Lu, Chunyan Ji, Keshu Zhou, Hongmei Jing, Hua Yang, Lanfang LI, Fei LI, Kailin Xu, Ting Niu, Depei Wu, Yu Hu, Wei-LI Zhao

Get full text

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma by Ru Li, Tingyu Wang, Rui Lyv, Yi Wang, Ying Yu, Yuting Yan, Qi Sun, Wenjie Xiong, Wei Liu, Weiwei Sui, Wenyang Huang, Huijun Wang, Chengwen Li, Jun Wang, Dehui Zou, Gang An, Jianxiang Wang, Lugui Qiu, Shuhua Yi

Get full text

Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis by Shuhua Yi, Yu Zhang, Wenjie Xiong, Weiwei Chen, Zhaohua Hou, Yang Yang, Yuting Yan, Yunbo Wei, Rui Cui, Huijun Wang, Zhen Yu, Heng Li, Zengjun Li, Wei Liu, Rui Lv, Tingyu Wang, Kun Ru, Dehui Zou, Minglei Shu, Lugui Qiu, Di Yu

Get full text

Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis by Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu

Get full text

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials by Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Zhiyue Huang, Huafei Lu, Yuqin Song, Yongping Song

Get full text

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma by Wei Liu, Yan Xu, Yi Wang, Huijun Wang, Jun Wei, Lugui Qiu, Huimin Liu, Jianxiang Wang, Weiwei Sui, Yin Shi, Hesong Zou, Wenyang Huang, Shuhua Yi, Dehui Zou, Lianting Chen, Rui Lv, Kefei Wang, Wenjie Xiong, Shuhui Deng, Guangxin Peng, Yueshen Ma, Lulu Lv, Wenting Zheng

Get full text

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia by Runxia Gu, Fang Liu, Dehui Zou, Yingxi Xu, Yang Lu, Bingcheng Liu, Wei Liu, Xiaojuan Chen, Kaiqi Liu, Ye Guo, Xiaoyuan Gong, Rui Lv, Xia Chen, Chunlin Zhou, Mengjun Zhong, Huijun Wang, Hui Wei, Yingchang Mi, Lugui Qiu, Lulu Lv, Min Wang, Ying Wang, Xiaofan Zhu, Jianxiang Wang

Get full text

YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial by Weiping Liu, Yufu Li, Quanshun Wang, Hang Su, Kaiyang Ding, Yuerong Shuang, Sujun Gao, Dehui Zou, Hongmei Jing, Ye Chai, Yicheng Zhang, Lihong Liu, Chunling Wang, Hui Liu, Jinying Lin, Haiyan Zhu, Chen Yao, Xiaoyan Yan, Meixia Shang, Shufang Wang, Fengyuan Chang, Xiaopei Wang, Jun Zhu, Yuqin Song

Get full text